Cas:190906-61-7 (3α,22α)-3,22-Dihydroxyurs-12-en-30-oic acid manufacturer & supplier

Chemical Name:(3α,22α)-3,22-Dihydroxyurs-12-en-30-oic acid

CAS.NO:190906-61-7

Synonyms:(3α,22α)-3,22-Dihydroxyurs-12-en-30-oic acid;Urs-12-en-30-oic acid, 3,22-dihydroxy-, (3α,22α)-

Molecular Formula:C₃₀H₄₈O₄

Molecular Weight:472.700

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:587.5±50.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.567

PSA:77.76000

Exact Mass:472.355255

LogP:7.27

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (3α,22α)-3,22-Dihydroxyurs-12-en-30-oic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Urs-12-en-30-oic acid, 3,22-dihydroxy-, (3α,22α)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Urs-12-en-30-oic acid, 3,22-dihydroxy-, (3α,22α)- Use and application,(3α,22α)-3,22-Dihydroxyurs-12-en-30-oic acid technical grade,usp/ep/jp grade.

Related News: OTL-101, by comparison, is designed to correct the problem by inserting working copies of the gene into a patient’s blood stem cells. 2,4-Dimethyloxazole manufacturers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. ethyl (2S)-3-(4-aminophenyl)-2-(1,3-dioxoisoindol-2-yl)propanoate,hydrochloride suppliers With the closing of AstraZeneca’s mega $39 billion buyout of Alexion Pharmaceuticals this week, the U.K. pharma has officially picked up Soliris and its successor, Ultomiris. 1-methyl-5-methylidene-2-oxoimidazole-4-carboxylic acid vendor & factory.